Navigate Up

UPMC/University of Pittsburgh Schools of the Health Sciences
For Journalists
Allison Hydzik
Telephone: 412-647-9975
Senior Director
Telephone: 412-586-9777

UPCI Secures Federal Contract For Up To $10M in Preclinical Cancer Drug Development Work

PITTSBURGH, Aug. 3, 2016 – The University of Pittsburgh Cancer Institute (UPCI), partner with UPMC CancerCancer, secured a highly prestigious contract from the National Cancer Institute (NCI) to perform preclinical research crucial to the development of new cancer drugs. This commitment could bring up to $10 million in research projects to UPCI over the next five years.
The contract cements UPCI’s role in all five stages of NCI’s drug development process, with UPCI researchers now holding funding mechanisms in drug screening, preclinical research, and Phase I, II and III clinical trials.
“It is exceedingly rare for an academic cancer institute to have funding in every one of these NCI drug development stages,” said Nancy E. Davidson, M.D., director of UPCI. “By being involved in every stage of NCI drug development, UPCI is able to truly consider and understand each part, bringing extra knowledge and value to every cancer drug research project we perform. Contracts like this are a crucial part of how we get the best therapies to our patients.”
Julie Eiseman, Ph.D., D.A.B.T., professor of pharmacology and chemical biology, and Jan Beumer, Pharm.D., Ph.D., D.A.B.T., associate professor of pharmaceutical sciences and medicine, both of UPCI, are co-principal investigators on the new NCI preclinical research contract. They also hold a previous NCI preclinical contract, which will conclude next year.
Under the new preclinical contract, UPCI will perform the research necessary to collect drug pharmacology data and determine the most efficacious routes and doses of proposed cancer drugs so that they can be used in human clinical trials. 
“What sets UPCI apart is that we provide an added value by being able to think outside the box,” said Dr. Beumer, who also is co-principal investigator on the NCI phase I clinical trial grant at UPCI. “We can connect these preclinical studies with the clinical trials that will follow and make suggestions to help both phases be as efficient and effective as possible.”
The researchers do not yet know specifically what potential drugs they’ll be investigating or which cancers they’ll ultimately be intended to tackle.
“That’s what we help to determine,” said. Dr. Eiseman. “In the past we’ve evaluated potential drugs for use in cancers of the colon, breast, pancreas, and head and neck, among others. It’s a team effort. No one person could develop these therapies alone.”
The Contract Number is HHSN2612016000221; the NCI Control Number is N02CM-2016-00022.

©  UPMC | Affiliated with the University of Pittsburgh Schools of the Health Sciences
Supplemental content provided by Healthwise, Incorporated. To learn more, visit

For help in finding a doctor or health service that suits your needs, call the UPMC Referral Service at 412-647-UPMC (8762) or 1-800-533-UPMC (8762). Select option 1.

UPMC is an equal opportunity employer. UPMC policy prohibits discrimination or harassment on the basis of race, color, religion, ancestry, national origin, age, sex, genetics, sexual orientation, gender identity, marital status, familial status, disability, veteran status, or any other legally protected group status. Further, UPMC will continue to support and promote equal employment opportunity, human dignity, and racial, ethnic, and cultural diversity. This policy applies to admissions, employment, and access to and treatment in UPMC programs and activities. This commitment is made by UPMC in accordance with federal, state, and/or local laws and regulations.

Medical information made available on is not intended to be used as a substitute for professional medical advice, diagnosis, or treatment. You should not rely entirely on this information for your health care needs. Ask your own doctor or health care provider any specific medical questions that you have. Further, is not a tool to be used in the case of an emergency. If an emergency arises, you should seek appropriate emergency medical services.

For UPMC Mercy Patients: As a Catholic hospital, UPMC Mercy abides by the Ethical and Religious Directives for Catholic Health Care Services, as determined by the United States Conference of Catholic Bishops. As such, UPMC Mercy neither endorses nor provides medical practices and/or procedures that contradict the moral teachings of the Roman Catholic Church.

Pittsburgh, PA, USA